Status:
UNKNOWN
A Model Based on Computed Tomography Imaging Parameters to Predict Poor Survival in Patients With Liver Cirrhosis
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18-75 years
Brief Summary
Cirrhosis, as the end stage of most chronic liver diseases, is an important clinical landmark portending high risk of death. Early identification and accurate prognostic scores is critical issue to im...
Detailed Description
Cirrosis, which is always manifesting as ascites, hepatic encephalopathy, upper gastrointestinal bleeding, severe jaundice and coagulopathy, deteriorates rapidly with a high mortality. Early identific...
Eligibility Criteria
Inclusion
- Age 18-75 years
- The diagnosis of liver cirrhosis based on imaging, laboratory and/or histological patameters from a board-certified hepatologist.
- Patients who underwent at least two abdominal CT examinations, and the interval between the first and the second check was more than one year.
- CT examination included the cross-sectional areas of muscle at L3 level.
- Basic patient data included age, gender, weight, height, biochemical examination, complications and 5-year survival.
- Biochemical examinations were available within 7 days before or after CT scan.
Exclusion
- patients with liver cancer and other malignant tumors.
- Patients accompanied by severe respiratory and circulatory diseases.
- Patients had a history of previous transplantation.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 15 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05208736
Start Date
March 1 2021
End Date
March 15 2023
Last Update
April 18 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital Xi'an Jiaotong University
Xi'an, Shannxi, China, 710061
2
First Affiliated Hospital, Xi'an Jiaotong University
Xi'an, Shannxi, China, 710061